Covered self-expandable metal stents for benign biliary strictures: a prospective multicenter trial

Covered self-expandable metal stents for benign biliary strictures: a prospective multicenter trial - PLAMET 2

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON37008

Enrollment

Registered

2009-04-21

Start date

2009-08-20

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign biliary obstruction CBD obstruction

Interventions

After informed consent, all patients included in this study will be given a covered SEMS following preceding dilation during ERCP.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Benign CBD obstruction confirmed with a CT scan and/or EUS - Serum bilirubin >50 mmol AND/OR clinical symptoms of an obstructive biliary stricture AND/OR CBD stricture seen during ERCP - Age > 18 years -Written informed consent -Stent placement feasible during ERCP;- Written informed consent

Exclusion criteria

Exclusion criteria: - Known history with hepatico-jejunostomy or choledocho jejunostomy or choledocho duodenostomy

Design outcomes

Primary

Measure	Time frame
Initial technical result; stent patency, complications, technical result of stent removal and long-term outcome	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)